These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22306098)

  • 1. Mycotic abdominal aortic aneurysm caused by toxigenic Clostridium difficile.
    Sathyendran V; Riley TV; Roberts SA; Freeman JT
    Anaerobe; 2012 Jun; 18(3):270-2. PubMed ID: 22306098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization and antimicrobial susceptibilities of Clostridium difficile clinical isolates from Victoria, Australia.
    Mackin KE; Elliott B; Kotsanas D; Howden BP; Carter GP; Korman TM; Riley TV; Rood JI; Jenkin GA; Lyras D
    Anaerobe; 2015 Aug; 34():80-3. PubMed ID: 25944720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
    Zheng L; Citron DM; Genheimer CW; Sigmon SF; Carman RJ; Lyerly DM; Goldstein EJ
    Anaerobe; 2007; 13(3-4):114-20. PubMed ID: 17531516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
    Freeman J; Baines SD; Todhunter SL; Huscroft GS; Wilcox MH
    J Antimicrob Chemother; 2011 Jun; 66(6):1407-8. PubMed ID: 21393199
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro antibiotic susceptibility profile of Clostridium difficile excluding PCR ribotype 027 outbreak strain in Hungary.
    Terhes G; Maruyama A; Latkóczy K; Szikra L; Konkoly-Thege M; Princz G; Nagy E; Urbán E
    Anaerobe; 2014 Dec; 30():41-4. PubMed ID: 25150212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridial infection of the abdominal aorta.
    Davies M; Byrne J; Harvey JS
    J Am Coll Surg; 2003 Aug; 197(2):331. PubMed ID: 12892819
    [No Abstract]   [Full Text] [Related]  

  • 7. Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.
    Knight DR; Giglio S; Huntington PG; Korman TM; Kotsanas D; Moore CV; Paterson DL; Prendergast L; Huber CA; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV
    J Antimicrob Chemother; 2015 Nov; 70(11):2992-9. PubMed ID: 26221017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the MICs of fidaxomicin and other antibiotics against Hungarian Clostridium difficile isolates.
    Eitel Z; Terhes G; Sóki J; Nagy E; Urbán E
    Anaerobe; 2015 Feb; 31():47-9. PubMed ID: 25139122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilocus sequence typing analysis and antibiotic resistance of Clostridium difficile strains isolated from retail meat and humans in Belgium.
    Rodriguez C; Taminiau B; Avesani V; Van Broeck J; Delmée M; Daube G
    Food Microbiol; 2014 Sep; 42():166-71. PubMed ID: 24929733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
    Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains.
    Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE
    Anaerobe; 2010 Dec; 16(6):633-5. PubMed ID: 20849968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyldepsipeptide antibiotics as a potential therapeutic agent against Clostridium difficile recurrent infections.
    Gil F; Paredes-Sabja D
    Future Microbiol; 2016 Sep; 11():1179-89. PubMed ID: 27546386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea.
    Kim J; Kang JO; Pai H; Choi TY
    Int J Antimicrob Agents; 2012 Jul; 40(1):24-9. PubMed ID: 22578765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of MCB3681 against Clostridium difficile strains.
    Rashid MU; Dalhoff A; Weintraub A; Nord CE
    Anaerobe; 2014 Aug; 28():216-9. PubMed ID: 25016084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Clostridium difficile toward antimicrobial agents used as feed additives for food animals.
    Aarestrup FM; Tvede M
    Microb Drug Resist; 2011 Mar; 17(1):125-7. PubMed ID: 20950192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance in European Clostridium difficile clinical isolates.
    Spigaglia P; Barbanti F; Mastrantonio P;
    J Antimicrob Chemother; 2011 Oct; 66(10):2227-34. PubMed ID: 21771851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Clostridium septicum in Vascular Surgery: A Case Report and Outcomes Literature Review.
    Alimi Y; Sosin M; Borsinger TM; Garrett JR; Salameh JR; Espinel CF
    Ann Vasc Surg; 2017 Aug; 43():314.e5-314.e11. PubMed ID: 28479472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult caecal malignancy leading to mycotic abdominal aortic aneurysm rupture.
    Hajir N; Macaulay E
    ANZ J Surg; 2010 Dec; 80(12):950. PubMed ID: 21114723
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden.
    Norén T; Alriksson I; Akerlund T; Burman LG; Unemo M
    Clin Microbiol Infect; 2010 Aug; 16(8):1104-10. PubMed ID: 19732094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.